The Effect of Cachexia On Survival In Metastatic Gastric Cancer Patients Treated With Best Supportive Care
In this retrospective study, we aimed to investigate the effect of cachexia on survival in metastatic gastric cancer (GC) patients treated with best supportive care (BSC) using real-life data. From 2015 to 2019, metastatic GC patients who were treated with BSC were included in this study. The study enrolled 53 metastatic GC patients, 36 (67.9%) were male and 17 (32.1%) were female . The median age of the patients was 66 years. The patients were assigned into two groups, according to body mass index (BMI): BMI
___
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.2. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Jr., Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583- 592.
3. Hamauchi S, Furuse J, Takano T, Munemoto Y, Furuya K, Baba H, et al. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer 2019; 125: 4294-302.
4. Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland EJ. Cancer Cachexia: Beyond Weight Loss. J Oncol Pract 2016; 12: 1163-1171.
5. Escamilla DM, Jarrett P. The impact of weight loss on patients with cancer. Nurs Times 2016; 112: 20-22.
6. Tarricone R, Ricca G, Nyanzi-Wakholi B, Medina-Lara A. Impact of cancer anorexiacachexia syndrome on health-related quality of life and resource utilisation: A systematic review. Crit Rev Oncol Hematol 2016; 99: 49- 62.
7. Blum D, Omlin A, Fearon K, Baracos V, Radbruch L, Kaasa S, et al. Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer 2010; 18: 273-279.
8. Takayama K, Atagi S, Imamura F, Tanaka H, Minato K, Harada T, et al. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Support Care Cancer 2016; 24: 3473-3480.
9. Takahari D, Boku N, Mizusawa J, Takashima A, Yamada Y, Yoshino T, et al. Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912. Oncologist 2014; 19: 358-366.
10. Hendifar AE, Chang JI, Huang BZ, Tuli R, Wu BU. Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy. J Gastrointest Oncol 2018; 9: 17-23.
11. Fukahori M, Shibata M, Hamauchi S, Kasamatsu E, Machii K. A retrospective cohort study to investigate the incidence of cancer-related weight loss during chemotherapy in gastric cancer patients. Support Care Cancer 2020.
12. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-495.
13. Mondello P, Lacquaniti A, Mondello S, Bolignano D, Pitini V, Aloisi C, et al. Emerging markers of cachexia predict survival in cancer patients. BMC Cancer 2014; 14: 828.
14. Argiles JM, Busquets S, Stemmler B, LopezSoriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 2014; 14: 754-762.
15. Arthur ST, Van Doren BA, Roy D, Noone JM, Zacherle E, Blanchette CM. Cachexia among US cancer patients. J Med Econ 2016; 19: 874- 880.
16. Chen X, Zeng Y, Huang Y, Xu J, Meng W, Wang X, et al. Preoperative Cachexia predicts poor outcomes in young rather than elderly gastric cancer patients: a prospective study. Cancer Manag Res 2019; 11: 8101-8110.
17. Kim CH, Park SM, Kim JJ. The Impact of Preoperative Low Body Mass Index on Postoperative Complications and Long-termSurvival Outcomes in Gastric Cancer Patients. J Gastric Cancer 2018; 18: 274-286.
18. Chen S, Nie RC, OuYang LY, Li YF, Xiang J, Zhou ZW, et al. Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination. World J Surg Oncol 2017; 15: 52.
19. Nobuoka D, Gotohda N, Kato Y, Takahashi S, Konishi M, Kinoshita T. Influence of excess body weight on the surgical outcomes of total gastrectomy. Surg Today 2011; 41: 928-934.
20. Lee HH, Park JM, Song KY, Choi MG, Park CH. Survival impact of postoperative body mass index in gastric cancer patients undergoing gastrectomy. Eur J Cancer 2016; 52: 129-137.
21. Wada T, Kunisaki C, Ono HA, Makino H, Akiyama H, Endo I. Implications of BMI for the Prognosis of Gastric Cancer among the Japanese Population. Dig Surg 2015; 32: 480- 486.
22. Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review. Gerontology 2014; 60: 294-305
- ISSN: 1301-0883
- Başlangıç: 1996
- Yayıncı: ERBİL KARAMAN
Sayıdaki Diğer Makaleler
The Evaluatıon of The Treatment Outcomes Wıth Pavlık Harness In Developmental Dysplasıa of The Hıp
Evaluation of Skin Prick Test Results In Patients With Atopic Dermatitis
Gurcan TURKYILMAZ, Sebnem Erol TURKYILMAZ, Emircan ERTÜRK, Onur KARAASLAN
Saadet Çınarsoy CİĞERİM, Seda KOTAN, Gönül DİNÇ
EUS Accuracy Against MRCP for Detection of Pancreaticobiliary Lesions
Mustafa Zanyar AKKUZU, Engin ALTINTAŞ, Serkan YARAŞ, Osman ÖZDOĞAN, Enver ÜÇBİLEK, Fehmi ATEŞ, Orhan SEZGİN, Ferzan AYDIN, Hatice Rızaoğlu BALCI, Yaren DİRİK
Analysis on Worldwide Coronavirus (COVID-19) Cases
Shıpra GUPTA, Jasmeet KALRA, Himanshu GOYAL, Vijay KUMAR
Sexual Function Disorders in Type 2 Diabetic Women; Cross-Sectional Study
MINE OZTÜRK, Saliha YILDIZ, Mustafa Sait GONEN
Surgeons Experience and Consistency To Determine Surgical Procedures For Hallux Valgus
Evrim SİRİN, Barış YILMAZ, Guzelali OZDEMİR, Erhan OKAY, Celaleddin BİLDİK, Dursun AK, Bülent EROL, Hasan Hilmi MURATLI
Gastrıc Intestınal Metaplasıa and Covıd 19 Infectıon
Mesut AYDIN, Ahmet cumhur DÜLGER, Serhat ÖZER, Yaren DİRİK, Sıddık KESKİN, Canan DEMİR